Evolving new treatments for patients with urothelial carcinoma now include antibody drug conjugates. In this podcast we explore how these work, where they fit into the available treatment options and the patient management strategies particularly for the latest treatments available to Australian patients. Helen Anderson, Genitourinary Cancer Nurse Navigator at the Gold Coast University Hospital is joined by Alex Mitchell, Cancer Care Co Ordinator from the Mater Hospital, Brisbane.